- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT04783922
An Update on Intracerebral Hemorrhage
An Update on Intracerebral Hemorrhage - A Cohort Study
The intracerebral hemorrhage study is a multicenter , combination of prospective and retrospective observational cohort study led by Dr. Muhammad Junaid Akram, PhD scholar at Chongqing Medical University. Prof Dr. Qi Li will be the senior consultant for the study. The study will be focusing on natural history, epidemiological , radiological, rehabilitative and clinical aspects as well as the effect of various treatments on the hemorrhagic patients.
The study related data of the patients diagnosed with intracerebral hemorrhage will be collected in prospective and retrospective ways. The prognostic data for the patients will be assembled and collected via using different outcome measures at different points of time.
Studieoversigt
Status
Betingelser
Detaljeret beskrivelse
Undersøgelsestype
Tilmelding (Forventet)
Kontakter og lokationer
Studiekontakt
- Navn: Muhammad Junaid Akram, DPT, MS-NMPT
- Telefonnummer: 0092-335-1402214
- E-mail: drjunaidmalik2@gmail.com
Undersøgelse Kontakt Backup
- Navn: Muhammad Junaid Akram
- Telefonnummer: 0092-335-1402214
- E-mail: drjunaidmalik2@gmail.com
Studiesteder
-
-
-
Islamabad, Pakistan, 46000
- Rekruttering
- Shifa tameer e millat university
-
Kontakt:
- Muhammad Junaid Akram, PhD*
- E-mail: drjunaidmalik2@gmail.com
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:
- Age > 18 years Patients willing to participate via signing a consent form' Patients diagnosed with CT-Confirmed spontaneous intracerebral hemorrhage (ICH) Patients willing to participate in the follow up assessment
Exclusion Criteria:
- Not willing to participate Secondary ICH to hemorrhagic infarction or tumor bleeding etc. Traumatic ICH
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Kohorter og interventioner
Gruppe / kohorte |
---|
Benign Hematoma
Patients (having novel image markers or clinical features) suggestive of a benign hematoma relatively , that is having relatively good prognostic outcome and less likely to expand.
|
Malignant Hematoma
Patients (having novel image markers or clinical features) suggestive of a malignant hematoma relatively, that is more likely to expand and have poor prognostic outcome.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
hæmatomvolumenvækst efter 24 timer
Tidsramme: 24 timer
|
At vurdere tidlig hæmatomvolumenvækst efter 24 timer
|
24 timer
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Functional outcome at 3 months assessed by modified Rankin Scale
Tidsramme: 3 months
|
Assess functional outcome at 3 months by using mRS
|
3 months
|
Early neurological deterioration assessed by NIHSS score at 24 hours
Tidsramme: 24 hours
|
To assess early neurological deterioration by using NIHSS score at 24 hours
|
24 hours
|
Early neurological deterioration assessed by NIHSS score at 48 hours
Tidsramme: 48 hours
|
To assess early neurological deterioration by using NIHSS score at 48 hours
|
48 hours
|
Early neurological deterioration assessed by NIHSS score at 72 hours
Tidsramme: 72 hours
|
To assess early neurological deterioration by using NIHSS score at 72 hours
|
72 hours
|
Perihematomal edema volume measurement at 24 hours
Tidsramme: 24 hours
|
To measure the perihematomal edema volume growth at 24 hours
|
24 hours
|
Perihematomal edema volume measurement at 48 hours
Tidsramme: 48 hours
|
To measure the perihematomal edema volume growth at 48 hours
|
48 hours
|
Perihematomal edema volume measurement at 72 hours
Tidsramme: 72 hours
|
To measure the perihematomal edema volume growth at 72 hours
|
72 hours
|
Intraventricular hemorrhage growth
Tidsramme: 24 hours
|
To assess the presence of IVH at 24 hours
|
24 hours
|
Major thrombotic events
Tidsramme: 2 weeks
|
To assess the thrombotic events 2 weeks after admission
|
2 weeks
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Muhammad Junaid Akram, DPT, MS-NMPT, Chongqing Medical University, Chongqing / Shifa Tameer e Millat University, Islamabad
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Forventet)
Studieafslutning (Forventet)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- IRB-Approval- Submitted
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .